Oncology News

Adeno-associated virus type 2, a type of DNA virus, was associated with oncogenic insertional mutagenesis in human hepatocellular carcinoma cells, according to data published in Nature Genetics.

Regen BioPharma, Inc. announced it is currently developing a gene delivery procedure that will enable RGBP-248, a gene silencing nucleic acid, to reach liver tumors and cancerous cells in the body faster and, in turn, treat unresectable liver cancer, according to a press release.

In a new study, researchers found that people who were obese in early adulthood had an increased risk for developing hepatocellular carcinoma later on, according to published findings.

The FDA has recently issued a number of gastroenterology-relevant communications, including bariatric and esophageal ablation device approvals, orphan drug designations for several cholangiocarcinoma treatments, fast track designation for a familial adenomatous polyposis drug, a draft guidance on clinical evaluation of gastroparesis drugs, and additional safety measures for ERCP duodenoscope reprocessing.

HIV providers were less likely than hepatologists to follow practice guidelines for hepatocellular carcinoma screening in patients with HIV/hepatitis B coinfection, according to recent data.

Scientists may have found a way to develop a new blood test for liver cancer using technology that is currently being used to analyze rocks and minerals, according to data presented at The Goldschmidt Conference in Prague.

Sirtex Medical Inc. announced its dose sales for SIR-Spheres Y-90 resin microspheres have increased by 21.2% in the U.S. for the second quarter of 2015 compared to the second quarter of 2014, according to a press release.

Researchers in Sweden found that women with intrahepatic cholestasis of pregnancy had an increased risk for developing late liver and biliary tree cancer, immune-mediated diseases and cardiovascular disease, according to published findings in the Journal of Hepatology.

In a retrospective cohort study, statin use was found to be associated with a reduced risk of hepatocellular carcinoma among patients with hepatitis B virus infection, according to study data.

In a new study published in Hepatology, researchers found temoporfin-photodynamic therapy prolonged bile ducts and could lead to increased overall survival in patients with nonresectable hilar bile duct cancer.